Clinical Trial Update: Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of silodosin for signs and symptoms of benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodosin (Silodosin)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED